Samsung Medical Center
Samsung Medical Center — peringkat ke-3 di seluruh dunia dalam bidang onkologi. Rumah sakit mitra MEDIWIN di bawah perjanjian rujukan pasien formal.
Search for the cost of a liver transplant or cancer treatment in Korea and you will find pages of confident price tables. Most of them are published by comparison websites that have no contract with any Korean hospital and no access to its pricing. They are estimates assembled from public fragments, and they exist to capture your enquiry and sell it on — often to a hospital in a different country entirely. MEDIWIN’s facilitator registration number is A-2022-01-01-4465, issued by the Seoul Metropolitan Government and valid to 29 June 2028 — you can ask any Korean agency for its number and check it.
MEDIWIN is a Korean government-registered facilitator with referral agreements with Samsung Medical Center, Asan Medical Center and Seoul St. Mary’s Hospital. Precisely because we work with these hospitals, we will not publish a fixed price for your operation. Only the hospital can issue a cost estimate, and it can only do so after its physicians have reviewed your records.
What we can do is tell you honestly what the bill is made of and what moves it, so that when the written estimate arrives you can read it.
1. Diagnostic work-up. Korean hospitals repeat imaging and pathology rather than relying on outside reports, particularly before surgery. This is not padding — staging errors are the most common reason a treatment plan changes after arrival. Expect PET-CT, MRI, biopsy and laboratory work in the first days.
2. The procedure itself. The largest single line. Driven by the operation chosen, whether it is open, laparoscopic or robotic, and the length of theatre time.
3. Inpatient stay. Room type, nursing level and intensive care days. For transplant and major cancer surgery this is a substantial share of the total, and it is the line most affected by complications.
4. Drugs and blood products. Chemotherapy agents, immunosuppressants after transplant, antimicrobials, transfusions. Some are far cheaper in Korea than in Western markets; some are not.
5. Non-medical costs. Interpretation, accommodation for accompanying family, transport, and living expenses over what is often a long stay. These are billed separately from the hospital and are frequently underestimated by patients — for a transplant they can approach the cost of a shorter treatment.
6. Facilitation fee. MEDIWIN charges a coordination fee for translation, submission and logistics. It is disclosed in writing before you commit, and it is never added to your medical bill — patients pay the hospital directly.
Stage of disease. The single largest factor. Early-stage disease treated with one operation and a short admission sits at one end; advanced disease requiring multimodal treatment over months sits at the other. The gap between them is not a percentage — it is a multiple.
Length of stay. Korean tertiary hospitals will state a minimum length of stay when they accept a case. Complications extend it, and the daily cost of an intensive care bed dominates any saving made elsewhere.
Whether a transplant needs a living donor. Living-donor transplantation involves two operations, two admissions and two work-ups. Donor evaluation alone is a significant cost, and it happens before anyone knows whether the donor is suitable.
What your home country will reimburse. Some national health systems and private insurers reimburse part of overseas treatment; most require pre-authorisation before you travel. This is worth resolving early, and it is a question for your insurer, not for us.
How to get a real figure. Submit a second opinion request with a short summary of the diagnosis. A coordinator sends a private secure link for your records, we translate and submit them, and the hospital returns a written estimate together with its medical opinion. There is no obligation to travel, and the estimate is the hospital’s, not ours.
For most procedures it is considerably less expensive than in the United States. Against Western Europe the comparison is narrower and depends heavily on what your own system would have covered. Cost is rarely the strongest argument for Korea in serious disease — surgical volume and waiting time usually matter more. If price is your only consideration, other destinations are cheaper than Korea.
Because they are not the ones who have to honour it. A figure published without seeing your records is a marketing number. A hospital that has reviewed your imaging and pathology can issue a written estimate; a website that has reviewed nothing cannot. Ask any site quoting a firm price which Korean hospital is contractually bound by it.
Facilitator fees in Korea are regulated. The Ministry of Health and Welfare sets maximum rates by hospital type, and the ceiling for tertiary university hospitals is lower than for clinics. Separately, MEDIWIN charges the patient a coordination fee, disclosed in writing in advance. What we never do is add a margin to your medical bill — you pay the hospital directly, at the hospital’s price.
No. Hospitals typically require a deposit against the estimate before admission and settle the balance at discharge, since the final figure depends on the actual course of treatment. The hospital states its own terms in the estimate. Never send money to an agency that asks you to pay medical fees into its own account — medical fees belong to the hospital.
Then say so, early. Some cases have a less costly treatment path that is medically reasonable, and the hospital can be asked. Some do not. We would rather tell you that plainly at the estimate stage than have you arrive in Korea and discover it. We do not arrange financing or lending.
Samsung Medical Center — peringkat ke-3 di seluruh dunia dalam bidang onkologi. Rumah sakit mitra MEDIWIN di bawah perjanjian rujukan pasien formal.
Rumah Sakit Umum
Rumah Sakit Umum
Kesehatan wanita, Rumah Sakit Umum